Filing Details
- Accession Number:
- 0001578563-23-000073
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-22 18:20:27
- Reporting Period:
- 2023-08-18
- Accepted Time:
- 2023-08-22 18:20:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1665988 | Bioventus Inc. | BVS | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1432665 | Iii P Anthony Bihl | 4721 Emperor Boulevard, Suite 100 Durham NC 27703 | Interim Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2023-08-18 | 13,290 | $4.14 | 138,290 | No | 4 | P | Direct | |
Class A Common Stock | Acquisiton | 2023-08-18 | 26,595 | $4.14 | 26,595 | No | 4 | P | Indirect | By Spouse's Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Indirect | By Spouse's Trust |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $3.89 to $4.405, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- Reflects shares directly held by The Irene A. Bihl Revocable Trust of which the Reporting Person and his spouse are trustees and among the beneficiaries. The Reporting Person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.